NOTV Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—Forward 3.72
EPS (TTM)$-1.920.0% YoY
Profit margin-13.5%HEALTHCARE
Market cap$10.7MMicro cap
Valuation
- Forward P/E
- 3.72
- PEG ratio
- —
- P/B
- 0.10
- P/S (TTM)
- 0.02
- EV/EBITDA
- 19.92
Profitability & growth
- ROE (TTM)
- -49.8%
- Operating margin
- -13.4%
- Revenue growth YoY
- 0.8%
- Dividend yield
- —
- Beta
- 3.83
Last earnings
Feb 9, 2026 · Estimate $-0.51 · Reported $-0.83
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Inotiv Inc
Company profileInotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 2701 KENT AVENUE, WEST LAFAYETTE, IN
- Fiscal year end
- September
- Latest quarter
- Dec 31, 2025
Market cap$10.7M
Shares outstanding$34.4M
52W high$3.32
52W low$0.22
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent